Ionis Pharmaceuticals Inc.

Ionis Pharmaceuticals Inc. is a biotechnology company dedicated to the discovery and development of RNA-targeted therapeutics. Its primary function is to create innovative treatments for a wide range of diseases, leveraging its pioneering antisense technology. Ionis’s pipeline includes drugs targeting neurological disorders, cardiovascular diseases, and rare diseases, showcasing its influence across multiple sectors of the healthcare industry. By focusing on antisense oligonucleotides, Ionis has carved a niche in the pharmaceutical landscape, underlining its expertise in addressing conditions with unmet medical needs. Ionis Pharmaceuticals collaborates with various leading pharmaceutical companies to enhance its research efforts and accelerate the commercialization of its products. Established in 1989 and headquartered in Carlsbad, California, Ionis continues to harness its scientific capabilities to deliver transformative therapies, positioning itself as an integral player in the advancement of precision medicine and pioneering genetic treatments. Its advancements drive significant interest and development in the field of RNA-based medicine, signifying its pivotal role in the biotechnological and pharmaceutical markets.